Insight certainty 4/5 debate potential 2/5

Walaliade: Health plans demand cost-saving proof over product engagement

Malinka Walaliyadde · a16z Podcast | Taking the Pulse on Bio · Jan 2, 2019 · at 18:59

Malinka Walaliade from Andreessen Horowitz's bio team explains why digital health startups initially target self-insured employers rather than traditional health insurance payers.

0:00 / 0:14exact quote · 14.5s
▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark
“Health insurance plans care a lot more about saving money than offering an engaging product and so for an early-stage startup, it's a lot harder for them to do the saving money piece, because that takes a long study to prove, and they do it eventually, but it's hard to do that initially, but they can show that it is an engaging product early.”

quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →

More from Malinka Walaliyadde

Assertion Partly supported
Walaliade: AI models outperform human physicians in top 2017 medical journals
“Two years ago, there weren't that many examples of prominent journals publishing AI and healthcare pieces where it was, you know, shown to work in healthcare context, and now it feels like every month there's a new nature paper or something coming out where, y…”
Malinka Walaliyadde Jan 2, 2019 ▶ 1:52 a16z Podcast | Taking the Pulse on Bio
Assertion Not checkable as stated
Walaliate: Genomics has few true healthcare applications 20 years after HGP
“We certainly haven't lived up to that, and in fact, it's been a little difficult to see exactly where genomics has had a true application today.”
Malinka Walaliyadde Jan 2, 2019 ▶ 1:19 a16z Podcast | When Will Genomics Live Up to the Hype?
Prediction Not checkable as stated
Walaliyadde: The magical continuous diagnostic machine of the future is your bathroom
“I actually think the magical diagnostic machine of the future is your bathroom.”
Malinka Walaliyadde Jan 2, 2019 ▶ 18:28 a16z Podcast | On the Genomics of Disease, From Science to Business
Assertion Partly supported
Walaliyadde: Assurex generated $60M in revenue despite only 20% test reimbursement
“There's a company called Assurex in mental health. They were making sixty million dollars in revenue last year, but they were only getting 20% of their tests reimbursed.”
Malinka Walaliyadde Jan 2, 2019 ▶ 24:40 a16z Podcast | On the Genomics of Disease, From Science to Business
Assertion Supported
Walaliade: Hospitals are increasingly taking financial risk for patient care
“Hospitals are increasingly taking financial risk on their patients. They are financially on the hook for excessive care.”
Malinka Walaliyadde Jan 2, 2019 ▶ 12:53 a16z Podcast | Taking the Pulse on Bio
Assertion Supported
Walaliyadde: One dominant company drove a decade of sequencing cost drops
“The dominant player in the sequencing machine space has almost entirely by itself been driving down the cost of sequencing over the last decade or so.”
Malinka Walaliyadde Jan 2, 2019 ▶ 4:15 a16z Podcast | On the Genomics of Disease, From Science to Business
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 1,000 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.